Jeffrey R. Weidner

Statistics

Publications

Citations

6.1K

H-Index

Active since

1991

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

Eli Lilly (United States)

National Institutes of Health

AbbVie (United States)

Cornell University

Jeffrey R. Weidner is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in life sciences, molecular biology, and enzymology.

Publications per year

1991–2020

Publications

A novel heterodimeric cysteine protease is required for interleukin-1βprocessing in monocytes

Nancy A. Thornberry, Herbert G. Bull, Jimmy Calaycay et al. · Nature · 1992 · 2.6K citations

Life Sciences, Immunology, Molecular Biology +12

Inducible nitric oxide synthase in pulmonary alveolar macrophages from patients with tuberculosis.

Susan Nicholson, Maria da Glória Bonecini-Almeida, José Roberto Lapa e Silva et al. · The Journal of Experimental Medicine · 1996 · 497 citations · Full text

Life Sciences, Immunology, Microbiology +17

Aggrecan degradation in human cartilage. Evidence for both matrix metalloproteinase and aggrecanase activity in normal, osteoarthritic, and rheumatoid joints.

Michael W. Lark, E K Bayne, J. Flanagan et al. · Journal of Clinical Investigation · 1997 · 472 citations · Full text

Medicine, Orthopaedic Surgery, Pathology +17

IL-1-converting enzyme requires aspartic acid residues for processing of the IL-1 beta precursor at two distinct sites and does not cleave 31-kDa IL-1 alpha

Andrew Howard, Matthew J. Kostura, Nancy A. Thornberry et al. · The Journal of Immunology · 1991 · 323 citations

Life Sciences, Biochemistry, Molecular Biology +15

Production of nitric oxide in the synovial membrane of rheumatoid and osteoarthritis patients.

Iain B. McInnes, Bernard P. Leung, Max Field et al. · The Journal of Experimental Medicine · 1996 · 289 citations · Full text

Medicine, Immunology, Pathology +17

1–5 of 28